Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN-BLMF vs BEMPEGALDESLEUKIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN-BLMF vs BEMPEGALDESLEUKIN: Safety Overview

Metric BELANTAMAB MAFODOTIN-BLMF BEMPEGALDESLEUKIN
Total FAERS Reports 150 174
Deaths Reported 60 22
Death Rate 40.0% 12.6%
Hospitalizations 36 159
Average Patient Age 65.9 yrs 64.9 yrs
% Female Patients 48.3% 23.6%
Marketing Status Prescription N/A